Evaluation of Monocyte Chemoattractant Protein 1(MCP-1) as a Predictor of Complications in Type 2 Diabetes Mellitus in Zagazig University Hospital - Egyptian Knowledge Bank - troweb

160038

Evaluation of Monocyte Chemoattractant Protein 1(MCP-1) as a Predictor of Complications in Type 2 Diabetes Mellitus in Zagazig University Hospital

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

EVALUATION OF MONOCYTE CHEMOTACTIC PROTEIN (MCP-1) IN SALIVA AS AN EARLY SIGN OF METABOLIC DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Article

MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IS ASSOCIATED WITH PANCREATIC BETA-CELL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS

Article

EVALUATION OF ANGIOPOIETIN-2 AS AN EARLY MARKER FOR DIABETIC NEPHROPATHY INZAGAZIG UNIVERSITY HOSPITALS

Article

Fetuin-A as a Marker of Insulin Resistance in Type 2 Diabetic Patients in Zagazig University

Article

Assessment of serum c-peptide level as a risk factor for atherosclerosis and myocardial dysfunction in Egyptian patients with type 2 DM

Thesis

Evaluation of monocyte chemotactic protein (MCP-1) in saliva as an early sign of metabolic disorders in patients with chronic kidney disease

Article

Evalution of Biomarkers in Iraq Patients with Diabetes Mellitus Type 2

Article

Monocyte Chemoattractant Protein-1 as a Diagnostic Marker for Detection of Hepatocellular Carcinoma in Egypt

Article

Study of serum monocyte chemoattractant protein-1 as a marker of disease activity in rheumatoid arthritis patients

Article

Evaluation of Bone Mineral Density among type 2 Diabetes Mellitus Patients in Zagazig University Hospitals